Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials

Jennifer G. Goldman*, Leah K. Forsberg, Bradley F. Boeve, Melissa J. Armstrong, David J. Irwin, Tanis J. Ferman, Doug Galasko, James E. Galvin, Daniel Kaufer, James Leverenz, Carol F. Lippa, Karen Marder, Victor Abler, Kevin Biglan, Michael Irizarry, Bill Keller, Leanne Munsie, Masaki Nakagawa, Angela Taylor, Todd Graham

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science